首页> 外文期刊>Journal of viral hepatitis. >Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure
【24h】

Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure

机译:HBV相关的慢性慢性肝衰竭患者急性肾损伤的临床特征和远期结局

获取原文
获取原文并翻译 | 示例
           

摘要

Acute kidney injury (AKI) is a common complication in patients with decompensated cirrhosis and is also an important cause for poor outcome. This study aimed at investigating the clinical characteristics and long-term prognosis of AKI in patients with hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF). A total of 1167 patients with HBV-related ACLF from January 2010 to January 2015 were enrolled and divided into two groups, AKI group (n=308) and non-AKI group (n=859). All patients were followed up to investigate clinical characteristics, long-term overall survival (OS) and risk factors. AKI occurrence was found to be 26.4% in patients with HBV-related ACLF. The patients in the AKI group and the non-AKI group had a 30-day OS of 44.8% and 70.3%, 90-day OS of 17.9% and 55.4%, and 1-year OS of 15.6% and 51.2%, respectively. Significant differences were observed in the 30-day, 90-day and 1-year OS among subgroups with different AKI stages. It was found that high WBC, neutrophil, ALT and MELD score were risk factors for 30-day mortality, whereas hepatic encephalopathy, high MELD score, mean arterial pressure and PLT were risk factors for 90-day mortality. Two criteria, the KDIGO and AKIN, showed parallel results in staging AKI in patients with HBV-related ACLF (=0.807, P<.001). AKI is closely associated with increased short-term mortality in Chinese HBV-related ACLF patients, particularly in those with infection and high MELD score. Both KDIGO and AKIN criteria can be used for staging AKI in patients with HBV-related ACLF.
机译:急性肾损伤(AKI)是失代偿性肝硬化患者的常见并发症,也是导致预后不良的重要原因。这项研究旨在调查与乙型肝炎病毒(HBV)相关的慢性慢性肝衰竭(ACLF)患者的AKI的临床特征和长期预后。从2010年1月至2015年1月,共纳入1167例HBV相关ACLF患者,分为AKI组(n = 308)和非AKI组(n = 859)。对所有患者进行随访,以调查其临床特征,长期总体生存率(OS)和危险因素。发现HBV相关ACLF患者的AKI发生率为26.4%。 AKI组和非AKI组的患者的30天OS分别为44.8%和70.3%,90天OS为17.9%和55.4%,1年OS为15.6%和51.2%。在不同AKI阶段的亚组中,在30天,90天和1年OS中观察到显着差异。研究发现,高白细胞,中性粒细胞,ALT和MELD评分是30天死亡率的危险因素,而肝性脑病,MELD评分高,平均动脉压和PLT是90天死亡率的危险因素。 KDIGO和AKIN这两个标准在HBV相关ACLF患者的AKI分期中显示出平行结果(= 0.807,P <.001)。 AKI与中国HBV相关ACLF患者的短期死亡率增加密切相关,特别是在那些感染和MELD评分高的患者中。 KDIGO和AKIN标准均可用于HBV相关ACLF患者的AKI分期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号